Профиль Polydex Pharmaceuticals LtdShs
Polydex Pharmaceuticals Ltd. engages in the manufacture and sale of bulk quantities of dextran and derivative products to large pharmaceutical companies. It develops and market biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.